Rational design of multifunctional magnetic mesoporous silica nanoparticle for tumor-targeted magnetic resonance imaging and precise therapy. (January 2016)

• Record Type: Journal Article
• Authors: Chen, Wei-Hai; Luo, Guo-Feng; Lei, Qi; Cao, Feng-Yi; Fan, Jin-Xuan; Qiu, Wen-Xiu; Jia, Hui-Zhen; Hong, Sheng; Fang, Fang; Zeng, Xuan; Zhuo, Ren-Xi; Zhang, Xian-Zheng
• Is Part Of: Biomaterials. Volume 76(2016)
• Page Start: 87
• Page End: 101
• Publication Date: 2016-01
• Subjects: Mesoporous silica nanoparticle -- Tumor-targeted -- Magnetic resonance imaging -- Theranostic -- Precise therapy; Biomedical materials -- Periodicals; Biocompatible Materials -- Periodicals; Biomatériaux -- Périodiques; 610.28
• DOI: 10.1016/j.biomaterials.2015.10.053
• Languages: English
• ISSNs: 0142-9612

Abstract

Abstract: In this paper, a multifunctional theranostic magnetic mesoporous silica nanoparticle (MMSN) with magnetic core was developed for magnetic-enhanced tumor-targeted MR imaging and precise therapy. The gatekeeper β-cyclodextrin (β-CD) was immobilized on the surface of mesoporous silica shell via platinum(IV) prodrug linking for reduction-triggered intracellular drug release. Then Arg-Gly-Asp (RGD) peptide ligand was further introduced onto the gatekeeper β-CD via host–guest interaction for cancer targeting purpose. After active-targeting endocytosis by cancer cells, platinum(IV) prodrug in MMSNs would be restored to active platinum(II) drug in response to the innative reducing microenvironment in cancer cells, resulting in the detachment of β-CD gatekeeper and thus simultaneously triggering the in situ release of anticancer drug doxorubicin (DOX) entrapped in the MMSNs to kill cancer cells. It was found that with the aid of an external magnetic field, drug loaded MMSNs showed high contrast in MR imaging in vivo and exhibited magnetically enhanced accumulation in the cancer site, leading to significant inhibition of cancer growth with minimal side effects. This multifunctional MMSN will find great potential as a theranostic nanoplatform for cancer treatment.